Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystcctomy

Canadian Journal of Anaesthesia

Volumn 46, Issue 10, 1999, Pages 991-993

  Fujii, Yoshitaka ^a   Saitoh, Yuhji ^b   Tanaka, Hiroyoshi ^b   Toyooka, Hidenori ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Toride Kyodo General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GRANISETRON; ISOFLURANE; NITROUS OXIDE PLUS OXYGEN; RAMOSETRON;

ADULT; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CYSTECTOMY; DRUG EFFICACY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LAPAROSCOPIC SURGERY; NAUSEA; POSTOPERATIVE ANALGESIA; PRIORITY JOURNAL; TREATMENT OUTCOME; VOMITING;

EID: 0032716346     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013138     Document Type: Article

References (7)

1. Fujii T, Tanaka H, Toyooka H. Granisetron reduces the incidence and severity of nausea and vomiting after laparoscopic cholecystectomy. Can J Anaesth 1997; 44: 396-400.
2. Fujii Y, Saitoh Y, Tanaka H, Toyooka H. Anti-emetic efficacy of prophylactic graniserton, droperidol and metoclopramide in the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, placebo-controlled trial. Eur J Anesthesiol 1988; 15: 166-71.
3. 3 receptor antagonistic and antiemetic effect in the ferret. (Japanese) Kiso to Rinsho 1996; 30: 1965-72.
4. Watcha MF, Wbite PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162-84.
5. Bermudez J, Boyle EA, Minter WD, Sanger GJ. The antiemetic potential of the 5hydroxytryptamine, receptor antagonist BRL 43694. Br J Cancer 1988; 58: 644-50.
6. 3 receptor antagonist: correlation with anti-emetic response. Cancer Chemother Pharmacol 1989; 24: 45-9.
7. Noda K, Ikeda M, Yoshida O, et al. Clinical evaluation of ramosetron against the nausea and vomiting induced by anticancer drugs. (Japanese) Jpn J Clin Exp Med 1994; 71: 2765-76.